Annual SG&A:
$97.30M+$21.68M(+28.67%)Summary
- As of today, RVMD annual SG&A is $97.30 million, with the most recent change of +$21.68 million (+28.67%) on December 31, 2024.
- During the last 3 years, RVMD annual SG&A has risen by +$66.85 million (+219.54%).
- RVMD annual SG&A is now at all-time high.
Performance
RVMD SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$40.58M+$5.57M(+15.91%)Summary
- As of today, RVMD quarterly SG&A is $40.58 million, with the most recent change of +$5.57 million (+15.91%) on June 30, 2025.
- Over the past year, RVMD quarterly SG&A has increased by +$18.87 million (+86.91%).
- RVMD quarterly SG&A is now at all-time high.
Performance
RVMD Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$7.43B-$812.06M(-12.27%)Summary
- As of today, RVMD TTM SG&A is -$7.43 billion, with the most recent change of -$812.06 million (-12.27%) on June 30, 2025.
- Over the past year, RVMD TTM SG&A has dropped by -$7.52 billion (-8150.67%).
- RVMD TTM SG&A is now -6672.80% below its all-time high of -$109.72 million.
Performance
RVMD TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
RVMD Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +28.7% | +86.9% | -8150.7% |
| 3Y3 Years | +219.5% | +297.7% | -10000.0% |
| 5Y5 Years | +684.3% | +697.1% | -10000.0% |
RVMD Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +219.5% | at high | +288.9% | -241.0% | at low |
| 5Y | 5-Year | at high | +684.3% | at high | +659.8% | -865.4% | at low |
| All-Time | All-Time | at high | +2041.7% | at high | +1579.6% | -6672.8% | at low |
RVMD Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $40.58M(+15.9%) | $127.77M(+17.3%) |
| Mar 2025 | - | $35.01M(+24.1%) | $108.90M(+12.6%) |
| Dec 2024 | $97.30M(+28.7%) | $28.21M(+17.8%) | $96.72M(-4.0%) |
| Sep 2024 | - | $23.96M(+10.4%) | $100.75M(+9.2%) |
| Jun 2024 | - | $21.71M(-4.9%) | $92.31M(+8.3%) |
| Mar 2024 | - | $22.84M(-29.2%) | $85.23M(+12.7%) |
| Dec 2023 | $75.62M(+86.3%) | $32.24M(+107.9%) | $75.62M(+39.3%) |
| Sep 2023 | - | $15.51M(+6.0%) | $54.29M(+10.3%) |
| Jun 2023 | - | $14.64M(+10.7%) | $49.21M(+9.9%) |
| Mar 2023 | - | $13.22M(+21.2%) | $44.77M(+10.3%) |
| Dec 2022 | $40.59M(+33.3%) | $10.91M(+4.6%) | $40.59M(+5.8%) |
| Sep 2022 | - | $10.43M(+2.3%) | $38.37M(+7.4%) |
| Jun 2022 | - | $10.20M(+12.9%) | $35.72M(+8.9%) |
| Mar 2022 | - | $9.04M(+4.0%) | $32.82M(+7.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $30.45M(+42.1%) | $8.69M(+11.6%) | $30.45M(+10.4%) |
| Sep 2021 | - | $7.79M(+6.8%) | $27.58M(+9.7%) |
| Jun 2021 | - | $7.30M(+9.4%) | $25.13M(+9.6%) |
| Mar 2021 | - | $6.67M(+14.5%) | $22.93M(+7.0%) |
| Dec 2020 | $21.43M(+72.7%) | $5.83M(+9.1%) | $21.43M(+8.4%) |
| Sep 2020 | - | $5.34M(+4.9%) | $19.77M(+12.8%) |
| Jun 2020 | - | $5.09M(-1.5%) | $17.53M(+15.6%) |
| Mar 2020 | - | $5.17M(+24.2%) | $15.16M(+22.2%) |
| Dec 2019 | $12.41M(+31.8%) | $4.16M(+34.1%) | $12.41M(+2.7%) |
| Sep 2019 | - | $3.10M(+13.9%) | $12.08M(+34.6%) |
| Jun 2019 | - | $2.73M(+12.8%) | $8.98M(+43.6%) |
| Mar 2019 | - | $2.42M(-37.0%) | $6.25M(+63.0%) |
| Dec 2018 | $9.41M(+107.1%) | $3.83M | $3.83M |
| Dec 2017 | $4.54M | - | - |
FAQ
- What is Revolution Medicines, Inc. annual SG&A?
- What is the all-time high annual SG&A for Revolution Medicines, Inc.?
- What is Revolution Medicines, Inc. annual SG&A year-on-year change?
- What is Revolution Medicines, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Revolution Medicines, Inc.?
- What is Revolution Medicines, Inc. quarterly SG&A year-on-year change?
- What is Revolution Medicines, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Revolution Medicines, Inc.?
- What is Revolution Medicines, Inc. TTM SG&A year-on-year change?
What is Revolution Medicines, Inc. annual SG&A?
The current annual SG&A of RVMD is $97.30M
What is the all-time high annual SG&A for Revolution Medicines, Inc.?
Revolution Medicines, Inc. all-time high annual SG&A is $97.30M
What is Revolution Medicines, Inc. annual SG&A year-on-year change?
Over the past year, RVMD annual SG&A has changed by +$21.68M (+28.67%)
What is Revolution Medicines, Inc. quarterly SG&A?
The current quarterly SG&A of RVMD is $40.58M
What is the all-time high quarterly SG&A for Revolution Medicines, Inc.?
Revolution Medicines, Inc. all-time high quarterly SG&A is $40.58M
What is Revolution Medicines, Inc. quarterly SG&A year-on-year change?
Over the past year, RVMD quarterly SG&A has changed by +$18.87M (+86.91%)
What is Revolution Medicines, Inc. TTM SG&A?
The current TTM SG&A of RVMD is -$7.43B
What is the all-time high TTM SG&A for Revolution Medicines, Inc.?
Revolution Medicines, Inc. all-time high TTM SG&A is -$109.72M
What is Revolution Medicines, Inc. TTM SG&A year-on-year change?
Over the past year, RVMD TTM SG&A has changed by -$7.52B (-8150.67%)